RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
Empagliflozin Increases Cardiac Energy Production in Diabetes Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors https://t.co/6HrQU8Gi7Z https://t.co/j5le6gD5pn
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @BertrandLuc_ky: Great paper from Lopaschuk lab: Empagliflozin Increases Cardiac Energy Production in Diabetes https://t.co/SJbtRpn5lq
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
RT @JACCJournals: How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAb…
How does treatment with empagliflozin lead to an enhanced cardiac energy pool? https://t.co/AUuYFdSZNi #JACCBTS #VisualAbstract https://t.co/6CpIwGI7k7
Great paper from Lopaschuk lab: Empagliflozin Increases Cardiac Energy Production in Diabetes https://t.co/SJbtRpn5lq
Editors’ Insights: Can SGLT2 inhibitor empagliflozin increase ATP production and prevent heart failure in a mouse diabetic model? Read the full study in the newest issue of #JACCBTS: https://t.co/4D3WkZ3rEv. https://t.co/4D3WkZ3rEv
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
This does make me wonder about the role of ketogenic diets in treating some types of cardiomyopathy/CHF. Is some of the mechanical dysfunction related to overuse of glycolysis and not use of FFA/ketones?
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
RT @DrWillWatson: https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP produ…
https://t.co/dkXbIGEDDw Great bit of work - SGLT2 actually altering cardiac metabolism and improving myocardial ATP production - proof that it perhaps isn't "just a diuretic"... #cardioed #empa https://t.co/0III1M2gym
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @rmiller_000: New Lopaschuk work showing heart substrate switching towards glucose and ketone. I want this to be the story of the empar…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @rmiller_000: New Lopaschuk work showing heart substrate switching towards glucose and ketone. I want this to be the story of the empar…
RT @rmiller_000: New Lopaschuk work showing heart substrate switching towards glucose and ketone. I want this to be the story of the empar…
RT @rmiller_000: New Lopaschuk work showing heart substrate switching towards glucose and ketone. I want this to be the story of the empar…
New Lopaschuk work showing heart substrate switching towards glucose and ketone. I want this to be the story of the empareg cvot, but my money is on volume contributing also. Great preview of the work by @ketonemics https://t.co/ujw3SU89eA
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…